PRECISION MEDICINE IN CLINICAL TREATMENT FOR HEPATOCELLULAR CARCINOMA PATIENTS WITH BCLC STAGE C

被引：0
|
作者：
Lin, Chih Wen [1 ,2 ]
Lo, Gio-Ho [1 ]
Lee, Po-Huang [3 ]
Wu, Tsung-Chin [4 ]
Yeh, Jen-Hao [4 ]
Hsiao, Pojen [4 ]
Chen, Yaw-Sen [3 ]
机构：
[1] E Da Hosp, Med, Kaohsiung, Taiwan
[2] I Shou Univ, Kaohsiung, Taiwan
[3] E Da Hosp, Surg, Kaohsiung, Taiwan
[4] E Da Dachang Hosp, Med, Kaohsiung, Taiwan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
368
引用
收藏
页码：234A / 234A
页数：1
相关论文
共 50 条
  • [21] BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy
    Lopez-Lopez, Victor
    Sanchez-Esquer, Ignacio
    Ramirez, Pablo
    Robles-Campos, Ricardo
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05) : 2367 - 2371
  • [22] BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A
    Jung, Young Kul
    Jung, Chang Ho
    Seo, Yeon Seok
    Kim, Ji Hoon
    Kim, Tae Hyung
    Yoo, Yang Jae
    Kang, Seong Hee
    Yim, Sun Young
    Suh, Sang Jun
    An, Hyunggin
    Yim, Hyung Joon
    Yeon, Jong Eun
    Byun, Kwan Soo
    Um, Soon Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 467 - 474
  • [23] Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
    Jiang Li
    Yu Hou
    Xiao-Bei Cai
    Bin Liu
    World Journal of Gastroenterology, 2016, (15) : 4034 - 4040
  • [24] Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
    Li, Jiang
    Hou, Yu
    Cai, Xiao-Bei
    Liu, Bin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (15) : 4034 - 4040
  • [25] Surgical Resection Versus Transarterial Chemoembolization for BCLC Stage C Hepatocellular Carcinoma
    Liu, Po-Hong
    Hsia, Cheng-Yuan
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lee, Rheun-Chuan
    Lin, Han-Chieh
    Huo, Teh-Ia
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (04) : 404 - 409
  • [26] TREATMENT OPTIONS IN INTERMEDIATE STAGE (BCLC B) HEPATOCELLULAR CARCINOMA: NOT ALWAYS TACE
    Pascual, Sonia
    Miralles, Cayetano
    Irurzun, Javier
    Bernabe, Juan M.
    Herrera, Ivan
    Hurtado, Ana
    Rodriguez, Maria
    Bellot, Pablo
    Gomez, Lucia
    HEPATOLOGY, 2022, 76 : S1371 - S1372
  • [27] Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
    Kikuchi, Luciana
    Chagas, Aline Lopes
    Alencar, Regiane S. S. M.
    Tani, Claudia
    Diniz, Marcio A.
    D'Albuquerque, Luiz A. C.
    Carrilho, Flair Jose
    CLINICS, 2017, 72 (08) : 454 - 460
  • [28] Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not
    Su, Jia-Yong
    Wang, Hong-Liang
    Chen, Qing-Qing
    Cai, Yu-Tong
    Tan, Jun-Shao
    Chen, Mei
    Tian, Wei
    Xie, Rong-Wei
    Ma, Liang
    Guo, Ping-Ping
    Zhong, Jian-Hong
    HELIYON, 2024, 10 (05)
  • [29] A NEW MODEL TO ESTIMATE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN BCLC B STAGE
    Ninomiya, Masashi Ninomiya
    Inoue, Jun
    Iwata, Tomoaki
    Sano, Akitoshi
    Tsuruoka, Mio
    Ueno, Yoshiyuki
    Masamune, Atsushi
    HEPATOLOGY, 2021, 74 : 613A - 614A
  • [30] Feasibility of Reductive Hepatectomy in Patients With BCLC B and C Hepatocellular Carcinoma
    Yasuhara, Yuki
    Komatsu, Shohei
    Kuramitsu, Kaori
    Kido, Masahiro
    Tanaka, Motofumi
    Gon, Hidetoshi
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Ajiki, Tetsuo
    Fukumoto, Takumi
    ANTICANCER RESEARCH, 2021, 41 (04) : 1975 - 1983
12345